Review dismisses claims youth suicides rose after NHS curbed puberty blockers

UK government adviser's report says claims not supported by data and could prompt under-18s to take own life

A government-ordered review has dismissed claims that suicide rates in young people with gender dysphoria have risen sharply since the NHS restricted access to puberty-blocking drugs.

A report by the government's adviser on suicide prevention also found that the claims - made by the campaign group the Good Law Project - were not supported by data and could prompt children under the age of 18 to take their own life.